KEY TAKEAWAY: The public sees profits made by pharmaceutical companies as a major factor contributing to the price of prescription drugs. Majorities of the public trust pharmaceutical companies (either “a lot” or “somewhat”) to be good stewards in terms of developing new effective drugs (71 percent), and offering reliable information to consumers about drug safety and side effects (65 percent) as well as drug efficacy (61 percent).
Continue reading
KEY TAKEAWAY: As it appears that the criticism of drug prices from politicians and the President has quieted down, companies are more aggressively and broadly pursuing drug price increases again.
Continue reading
KEY TAKEAWAY: Trump’s threat to issue an executive order on drug pricing, if issued, will be overturned as “unconstitutional”. There are no quick fixes to rein on excessive healthcare costs. They can only be addressed through a thorough bipartisan review of the way our healthcare system function.
Continue readingKEY TAKEAWAY: So far in 2019, more than 3,400 drugs have boosted their prices, a 17% increase compared with the roughly 2,900 drug price increases at the same time in 2018, according to a new analysis by Rx Saving Solutions, a consultant to health plans and employers. The average price hike for those 3,400 drugs stands at 10.5% or about 5 times the rate of inflation, the study found.
Continue reading
